Загрузка...
A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
INTRODUCTION: Psoriasis is a chronic immune-mediated inflammatory skin disease that occurs in 2.5–3.5% of the general population. Infliximab (INF), a TNF-α inhibitor biologic agent, is a long-standing efficacious treatment for psoriasis; however, not all patients sustain a long-term response (LTR) b...
Сохранить в:
| Опубликовано в: : | Dermatol Ther (Heidelb) |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477063/ https://ncbi.nlm.nih.gov/pubmed/32816254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-020-00436-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|